Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neurocrine Bioscienc
(NQ:
NBIX
)
152.55
+0.28 (+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
381,506
Open
152.50
Bid (Size)
138.00 (1)
Ask (Size)
154.80 (1)
Prev. Close
152.27
Today's Range
150.20 - 152.68
52wk Range
103.63 - 157.98
Shares Outstanding
100,900,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
Today 15:22 EDT
Drug companies are investing in schizophrenia treatments as patients are desperate for a drug that has few side effects, Bloomberg reports.
Via
Benzinga
Why the quality investor may take a look at NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
August 22, 2024
Is NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) suited for quality investing?
Via
Chartmill
Performance
YTD
+15.81%
+15.81%
1 Month
+5.03%
+5.03%
3 Month
+8.59%
+8.59%
6 Month
+12.14%
+12.14%
1 Year
+42.73%
+42.73%
More News
Read More
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
August 19, 2024
Via
Benzinga
NASDAQ:NBIX—A High-Growth Stock Gearing Up for Its Next Upward Move.
August 19, 2024
Via
Chartmill
NASDAQ:NBIX is not too expensive for the growth it is showing.
August 19, 2024
Via
Chartmill
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
August 01, 2024
Via
Benzinga
NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
July 26, 2024
Via
Chartmill
NASDAQ:NBIX, a growth stock which is not overvalued.
July 26, 2024
Via
Chartmill
New Study Reveals How Classical Music Could Revolutionize Depression Care
August 12, 2024
Via
PressReach
Exposures
Product Safety
So Much For Expecting The Fed To Stick The Landing
August 04, 2024
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
August 02, 2024
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Should Quality Investors Include NASDAQ:NBIX in Their Portfolio?
July 25, 2024
Via
Chartmill
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Via
Benzinga
Why NASDAQ:NBIX Is a Promising High-Growth Stock in the Midst of Consolidation.
July 05, 2024
Via
Chartmill
NASDAQ:NBIX is not too expensive for the growth it is showing.
July 05, 2024
Via
Chartmill
Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors.
July 04, 2024
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued.
June 20, 2024
Via
Chartmill
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Via
InvestorPlace
Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock?
June 14, 2024
Via
Chartmill
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Via
Benzinga
Exploring NASDAQ:NBIX's quality characteristics.
May 27, 2024
Via
Chartmill
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
May 24, 2024
Via
Chartmill
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation.
June 13, 2024
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.